HanchorBio

HanchorBio Inc. is a global clinical-stage biotechnology company developing next-generation immunotherapies for oncology and immune-mediated diseases. Our strategy is built around macrophage and myeloid biology. Through our proprietary Fc-Based Designer Biologics (FBDB™) platform, we engineer differentiated, multi-functional biologics designed to activate innate and adaptive immunity and address limitations of existing immunotherapies.